Case Comprehensive Cancer Center

Researchers at Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D). Alzheimer’s disease is a brain disorder…

Johnie Rose, MD, PhD, member of Case CCC's Population and Cancer Prevention Program and Director of CWRU SOM's Preventive Medicine Residency Program, has received a $1.5M award from the National Cancer Institute to develop a first-of-its-kind, transportable informatics tool that will integrate…

Case CCC Immune Oncology Program member, Amar Desai, PhD, has been awarded $100,000 in funding for one year from the Innovative Science Accelerator Program (ISAC) for his project Antihistamines to prevent age-associated hematopoietic decline. He aims to demonstrate that repurposing a well tolerated…

Research could lead to new discoveries in cancer medicine With a new five-year, $1.9 million grant from the National Institute of General Medical Sciences (NIGMS), researchers at Case Western Reserve University will develop computer software to analyze and interpret complex genome…

With a new four-year, $1.14 million grant from the U.S. Department of Veterans Affairs, researchers at Case Western Reserve University and the Louis Stokes Cleveland VA Medical Center, will use artificial intelligence (AI) to determine the best personalized treatment for veterans with rectal…

The Alumni Association of Case Western Reserve University will host the next installment of Spartans Step Up, a webcast series focusing on topical issues and the CWRU community, Wednesday, Sept. 18, from 1 to 2 p.m. Gary Schwartz, director of the Case Comprehensive Cancer Center and vice dean of…

At 4 years old, Charis Eng was captivated by her uncle’s career as a physician—an early fascination that wound up shaping her future. By age 16, she had already enrolled at the University of Chicago, marking the start of a journey that would eventually lead her to become a pioneering figure in…

Robert Salata, MD, member of Case CCC's Population and Cancer Prevention Program, leading figure in the field of infectious diseases, and dedicated advocate for public health, passed away this week. His distinguished career at CWRU and University Hospitals spanned decades, during which he mentored…

A study published in Nature's Scientific Reports by Case CCC Molecular Oncology Program members Edward Plow, PhD, and Khalid Sossey-Alaoui, PhD, suggests that Kindlin-2 should be closely examined as a therapeutic target for prostate cancer treatment. Titled Role of Kindlin 2 in prostate cancer,…

January 2022 debuted Reshmi Parameswaran's novel B-cell activating factor (BAFF) CAR T product effective at killing multiple B-cell cancers with robust in vitro and in vivo cytotoxicity exerted by these cells against mantle cell lymphoma, multiple myeloma, and acute lymphoblastic leukemia. This…